Author:
Akutagawa Kayo,Iwakiri Ryuichi,Hara Megumi,Fujimoto Kazuma,Fujiwara Yasuhiro,Inamori Masahiko,Tanaka Junji,Shimatani Tomohiko,Akiyama Junichi,Ando Takashi,Manabe Noriaki,Kinjo Fukunori,Deguchi Ryuzo,Kusano Motoyasu
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Fass R. Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease. Am J Gastroenterol. 2003;98:S2–7.
2. Vakil N. van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20.
3. Kawagichi H, Haruma K, Komoto K, Yoshihara M, Sumii K, Kajiyama G. Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol. 1996;91:959–62.
4. Watanabe A, Iwakiri R, Yamaguchi D, Higuchi T, Tsuruoka N, Miyahara K, Akutagawa K, Sakata Y, Fujise T, Oda Y, Shimoda R, Sakata H, Fujimoto K. Risk factors for resistance to proton pump inhibitor maintenance therapy for reflux esophagitis in Japanese women over 60 years. Digestion. 2012;86:323–8.
5. Fujimoto K. Prevalence and epidemiology of gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther. 2004;20:5–8.